Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$15.36 - $27.51 $224,501 - $402,086
-14,616 Reduced 50.57%
14,287 $354,000
Q1 2022

May 16, 2022

SELL
$22.22 - $39.12 $1.41 Million - $2.48 Million
-63,436 Reduced 68.7%
28,903 $725,000
Q4 2021

Feb 14, 2022

BUY
$18.38 - $40.5 $540,390 - $1.19 Million
29,401 Added 46.71%
92,339 $3.36 Million
Q3 2021

Nov 15, 2021

SELL
$13.18 - $19.83 $2.06 Million - $3.1 Million
-156,465 Reduced 71.31%
62,938 $1.08 Million
Q2 2021

Aug 16, 2021

BUY
$9.59 - $50.88 $2.1 Million - $11.2 Million
219,403 New
219,403 $2.94 Million
Q4 2020

Feb 16, 2021

SELL
$47.25 - $65.16 $2.95 Million - $4.07 Million
-62,458 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$46.35 - $61.69 $2.89 Million - $3.85 Million
62,458 New
62,458 $3.42 Million
Q2 2020

Aug 14, 2020

SELL
$38.58 - $65.07 $209,219 - $352,874
-5,423 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$32.73 - $50.78 $1.7 Million - $2.64 Million
-51,970 Reduced 90.55%
5,423 $218,000
Q4 2019

Feb 14, 2020

SELL
$6.81 - $39.55 $458,258 - $2.66 Million
-67,292 Reduced 53.97%
57,393 $2.27 Million
Q3 2019

Nov 14, 2019

SELL
$6.47 - $8.96 $608,277 - $842,374
-94,015 Reduced 42.99%
124,685 $845,000
Q2 2019

Aug 14, 2019

BUY
$8.31 - $14.85 $1.26 Million - $2.25 Million
151,482 Added 225.36%
218,700 $2.03 Million
Q1 2019

May 15, 2019

SELL
$10.01 - $13.89 $41,891 - $58,129
-4,185 Reduced 5.86%
67,218 $934,000
Q4 2018

Feb 14, 2019

SELL
$9.15 - $12.26 $151,633 - $203,172
-16,572 Reduced 18.84%
71,403 $779,000
Q3 2018

Nov 14, 2018

BUY
$10.49 - $13.72 $40,082 - $52,424
3,821 Added 4.54%
87,975 $1.11 Million
Q2 2018

Aug 14, 2018

BUY
$10.62 - $13.98 $893,715 - $1.18 Million
84,154 New
84,154 $1.11 Million
Q1 2018

May 15, 2018

SELL
$5.9 - $14.99 $133,186 - $338,384
-22,574 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$5.53 - $8.42 $52,081 - $79,299
9,418 Added 71.59%
22,574 $134,000
Q3 2017

Nov 14, 2017

BUY
$6.5 - $10.69 $85,514 - $140,637
13,156
13,156 $98,000

Others Institutions Holding CCXI

About ChemoCentryx, Inc.


  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.